[The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
Syrkin
A L
AL
Kogan
A Kh
AKh
Drinitsina
S V
SV
Kuznetsov
A B
AB
Pechorina
E A
EA
Frenkel'
E E
EE
Kuleshova
N N
NN
Golovnia
L D
LD
D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D000975:Antioxidants / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003067:Coenzymes; D019610:Cytoprotection / Q000187:drug effects*; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D009206:Myocardium / Q000166:cytology*; D005082:Physical Exertion; D013997:Time Factors; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000975:Antioxidants; D002317:Cardiovascular Agents; D003067:Coenzymes; D014451:Ubiquinone; C024989:coenzyme Q10